E193 E193 (Zonisamide 25 mg)
Pill with imprint E193 E193 is Orange / Gray, Capsule-shape and has been identified as Zonisamide 25 mg. It is supplied by Sandoz Pharmaceuticals Inc..
Zonisamide is used in the treatment of seizures; migraine prevention; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E193 E193
Zonisamide
- Imprint:
- E193 E193
- Strength:
- 25 mg
- Color:
- Orange / Gray
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sandoz Pharmaceuticals Inc.
- Inactive Ingredients:
- microcrystalline cellulose
ferrosoferric oxide
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
hydrogenated castor oil
sodium lauryl sulfate
titanium dioxide
Note: Inactive ingredients may vary.
More about zonisamide
- Zonisamide Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 88 Reviews
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (2)
Consumer resources
Other brands: Zonegran
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
